Private Health Insurance (Prostheses Application and Listing Fee) Rules 2007 (No. 2) (Cth)
Private Health Insurance (Prostheses Application and Listing Fee) Rules 2007 (No. 2)
I, ANTHONY JOHN ABBOTT, Minister for Health and Ageing, make these Rules under section 8 of the Private Health Insurance (Prostheses Application and Listing Fees) Act 2007.
Dated ______19/7/07__________
__________Tony Abbott_______________
Minister for Health and Ageing
Contents
Part 1 Preliminary 3
1.Name of Rules 3
2.Commencement 3
3.Revocation 3
4.Definitions 3
Part 2 Fees 4
5.Application fees 4
6.Initial listing fee 4
7.Ongoing listing fee 4
8.Transitioned applications 4
9.First ongoing listing fee following grant of application 4
10.Ongoing listing fee imposition day 4
Part 1 Preliminary
Name of Rules
These Rules are the Private Health Insurance (Prostheses Application and Listing Fee) Rules 2007 (No. 2).
Commencement
These Rules commence on 14 July 2007.
Revocation
The Private Health Insurance (Prostheses Application and Listing Fee) Rules 2007 are revoked.
Definitions
In these Rules:
Act means the Private Health Insurance (Prostheses Application and Listing Fees) Act 2007.
human tissue prosthesis means a product that is substantially derived from human tissue where the tissue has been subjected to processing or treatments and the supply (however described, including trade, sell, give or gift) of which is governed by State or Territory law.
Private Health Insurance Act means the Private Health Insurance Act 2007.
Part 2 Fees
Application fees
For subsection 3 (1) of the Act, the application fee for an application made under subsection 72-10 (2) of the Private Health Insurance Act is:
(a)in relation to a human tissue prosthesis―nil; and
(b)in relation to any other prosthesis―$400.
Initial listing fee
For subsection 4 (1) of the Act, the initial listing fee for the purposes of subsection 72-10 (5) of the Private Health Insurance Act is:
(a)for a human tissue prosthesis―nil; and
(b)for any other prosthesis―$110.
Ongoing listing fee
For subsection 4 (3) of the Act, the ongoing listing fee for the purposes of section 72-15 of the Private Health Insurance Act is:
(a)for a human tissue prosthesis―nil;
(b)for any other prosthesis―$110.
Transitioned applications
Despite rule 6, for subsection 4 (1) of the Act, the initial listing fee for an application to which rule 7 of the Private Health Insurance (Transition) Rules 2007 applies is, and is taken always to have been, nil.
First ongoing listing fee following grant of application
Despite rule 7, for subsection 4 (3) of the Act, the ongoing listing fee imposed on the ongoing listing fee imposition day immediately following the granting of an application is nil.
Ongoing listing fee imposition day
For subsection 4 (4) of the Act, the following days of each year are specified as ongoing listing fee imposition days:
(a)15 January; and
(b)15 July.
Note: The ongoing listing fee must be paid within 28 days of each ongoing listing fee imposition day―see subsection 72-15 (2) of the Private Health Insurance Act.
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See
0
0
0